FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $58,086 | +85.1% | 15,531 | +4.9% | 0.01% | +57.1% |
| Q3 2023 | $31,389 | -45.6% | 14,806 | +22.1% | 0.01% | -41.7% |
| Q2 2023 | $57,729 | -7.9% | 12,128 | +10.3% | 0.01% | -33.3% |
| Q1 2023 | $62,677 | -43.1% | 10,996 | +0.8% | 0.02% | -83.2% |
| Q4 2022 | $110,122 | -56.0% | 10,914 | -2.1% | 0.11% | -53.5% |
| Q3 2022 | $250,000 | -12.0% | 11,146 | -2.7% | 0.23% | +6.5% |
| Q2 2022 | $284,000 | -42.4% | 11,452 | -9.9% | 0.22% | -6.9% |
| Q1 2022 | $493,000 | -42.2% | 12,708 | -12.8% | 0.23% | -25.4% |
| Q4 2021 | $853,000 | – | 14,577 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |